Skip to main content
. 2019 Nov 14;9:1218. doi: 10.3389/fonc.2019.01218

Table 1.

Patient characteristics for the training and validation cohorts.

Variables Training cohort Validation cohort P-value
N % N %
700 49.1 727 50.9
Age (year) 0.056
<60 462 (66.0) 514 (70.7)
≥60 238 (34.0) 213 (29.3)
Menopausal status 0.439
Premenopause 231 (33.0) 226 (31.1)
Postmenopause 469 (67.0) 501 (68.9)
Depth of myometrial invasion <0.001
<50% 544 (77.7) 494 (68.0)
≥50% 156 (22.3) 233 (32.0)
Cervical stromal invasion <0.001
No 631(90.1) 574 (79.0)
Yes 69 (9.9) 153 (21.0)
Histological grade <0.001
G1 250(35.7) 178 (24.5)
G2 304(43.4) 371 (51.0)
G3 146(20.9) 178 (24.5)
Histological type 0.068
Endometrioid 637 (91.0) 640 (88.0)
Non-endometrioid 63 (9.0) 87 (12.0)
Tumor diameter <0.001
<2 266(38.0) 177 (24.3)
≥2 434(62.0) 550 (75.7)
Lymphovascular space invasion 0.807
No 584 (83.4) 610 (83.9)
Yes 116 (16.6) 117 (16.1)
Lymph node metastasis 0.016
No 644 (92.0) 641 (88.2)
Yes 56 (8.0) 86 (11.8)

Data are n (%) or mean± SD. Bold represents P-value of the variable is less than 0.05.